High Tower Advisors, LLC P Lx Pharma Inc. Transaction History

High Tower Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	SELL	$0.15 - $0.63 $487 - $2,047	-3,250 Reduced 10.92%	26,507 $4,000
Q2 2022 Aug 10, 2022	SELL	$1.9 - $4.18 $5,700 - $12,540	-3,000 Reduced 9.16%	29,757 $73,000
Q1 2022 May 12, 2022	BUY	$3.54 - $8.3 $41,354 - $96,960	11,682 Added 55.43%	32,757 $131,000
Q4 2021 Feb 10, 2022	SELL	$7.69 - $19.66 $17,948 - $45,886	-2,334 Reduced 9.97%	21,075 $169,000
Q3 2021 Nov 12, 2021	BUY	$12.22 - $21.28 $286,057 - $498,143	23,409 New	23,409 $452,000

62.7K

Ticker PLXP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,137,700
Description
PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.